Track: Pediatric Cancer

Pediatric Cancer

Pediatric Cancer session will emphasize advancements in treatment, including targeted therapies, immunotherapy, and personalized medicine tailored for pediatric patients. Participants will learn about ongoing clinical trials, new research directions, and how innovations in precision medicine are transforming outcomes for young cancer patients. Interactive discussions will encourage participants to share perspectives and consider collaborative approaches to advancing pediatric oncology care.

Leukemia
Explore the latest advancements in leukemia research, innovative diagnostic techniques, and emerging therapies. Engage with leading experts to understand the complexities of leukemia and its evolving treatment landscape, fostering hope for improved patient outcomes.

Brain and CNS Tumors
Explore the latest advancements in diagnosing and treating brain and central nervous system tumors. This sub-session delves into groundbreaking research, innovative therapies, and challenges in enhancing patient outcomes and quality of life.

Neuroblastoma
Explore the latest advancements in diagnosing, treating, and managing neuroblastoma, a challenging pediatric cancer. Neuroblastoma sub-session highlights innovative research, targeted therapies, and multidisciplinary approaches to improve outcomes and quality of life for young patients.

Wilms Tumor
Explore the latest advancements in diagnosing and treating Wilms Tumor, a rare kidney cancer in children. This sub-session highlights breakthroughs in genetic research, early detection strategies, and innovative therapies aimed at improving survival rates and patient outcomes

Lymphomas
Explore the complexities of lymphomas, including Hodgkin's and non-Hodgkin's types. This sub-session will cover advances in diagnosis, staging, and treatment strategies such as chemotherapy, immunotherapy, and targeted therapies. Discussions will focus on improving patient care and current research trends.

Bone Cancers
Explore the various types of bone cancers, including osteosarcoma and Ewing sarcoma, focusing on diagnosis, treatment approaches, and challenges. Bone Cancers sub-session will cover surgical techniques, radiation therapy, chemotherapy, and innovative research aimed at improving outcomes for bone cancer patients.